Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Transcriptional analysis of mantle cell lymphoma - a global search for cellular origin and therapeutic targets

Publiceringsår: 2004
Språk: Engelska
Sidor: 145
Dokumenttyp: Doktorsavhandling
Förlag: Department of Immunotechnology, Box 7031 220 07 LUND,
Ytterligare information: Article: Ek, S., Högerkorp, C-M., Dictor, M., Ehinger, M., Borrebaeck, C.A.K (2002)“Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared to subpopulations of normal human B cells” Cancer Res 62(15): 4398-405. Article: Ek, S., Björck, E., Högerkorp, C-M., Walsh, S.H., Thorselius, M., Rosenquist, R., Nordenskjöld, M., Porwit-MacDonald, A., Borrebaeck, C.A.K“Mantle cell lymphomas overexpress CCL4, CCL5 and 4-1BB ligand and show evidence of an activated B cell origin” (submitted 2004) Article: Ek, S., Björck, E., Nordenskjöld, M., Porwit-MacDonald, A., Borrebaeck, C.A.K“Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis” Haematologica. In press, 2004;89:686-695 Article: Ek, S., Ortega, E., Borrebaeck, C.A.K“Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma” (submitted 2004)


This thesis is based upon four original papers describing the characterisation of mantle cell lymphoma (MCL) tumours and cell lines in comparison with different populations of normal B cells. Gene expression profiling, which were used in the studies, has during recent years developed as an important tool in characterisation of different types of malignancies. In this thesis, the technique is used to identify gene signatures in addition to providing information about the mRNA expression of more than 10 000 genes in the samples analysed. We found indications of an antigen-activated origin of MCL, in contrast to the current dogma. De-regulation of apoptosis and proliferation-associated pathways were further identified and possibly therapeutic targets were recognised. In an attempt to define the differences between high and low proliferative MCL, a proliferation-associated signature was established. The genes or gene-products constituting the signature are potential targets for therapy, as the genes are associated with proliferation, which is related to decreased survival time. Furthermore, MCL cell lines were studied to determine their usefulness as in vitro models for MCL. Hierarchical clustering, using a MCL-specific gene list, confirmed that the cell lines had preserved the expression of MCL-associated genes, as they were readily separate from other lymphoma cell lines, primary follicular lymphoma samples and normal B cells. However, one of the MCL-derived cell lines showed less correlation to the primary MCL tumours than the other cell lines. The same cell line carried a mutated VH gene, in contrast to the other MCL cell lines, and may be more suitable as in vitro model for MCL with mutated than unmutated VH genes.


Lundmarksalen, Inst för Astronomi, Sölvegatan 27, Lund.
  • Harmut Merz (Professor)


  • Immunology in the medical area
  • cancer
  • oncology
  • cancerology
  • Cytologi
  • onkologi
  • Cytology
  • somatic mutation
  • microarray
  • tumour
  • mantle cell lymphoma
  • B cell


  • ISBN: 91-7422-052-7

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen